ABO incompatible renal transplantation following lung transplantation.
We present management strategies utilised for the first case of an urgent live-donor ABO incompatible B blood group renal transplant, in a patient with a prior A blood group lung transplant for cystic fibrosis. Three years on, renal function is excellent and stable, whilst lung function has improved.
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia. Electronic address: g.snell@alfred.org.au.
G I
GI
Snell
Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australia.
A K
AK
Davis
Department of Renal Medicine, Alfred Hospital and Monash University, Melbourne, Australia.
S
S
Menahem
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia.
S
S
Kotecha
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia.
H M
HM
Whitford
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia.
B J
BJ
Levvey
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia.
M
M
Paraskeva
Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australia.
A
A
Webb
Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia.
G W
GW
Westall
Department of Renal Medicine, Alfred Hospital and Monash University, Melbourne, Australia.
R G
RG
Walker
D000017:ABO Blood-Group System / Q000276:immunology*; D000208:Acute Disease; D000328:Adult; D003550:Cystic Fibrosis / Q000628:therapy*; D018572:Disease-Free Survival; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007519:Isoantigens / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation; D019520:Living Donors; D016040:Lung Transplantation; D008875:Middle Aged; D009035:Mothers; D009173:Mycophenolic Acid / Q000627:therapeutic use; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D018805:Sepsis / Q000628:therapy*; D016559:Tacrolimus / Q000627:therapeutic use; D028761:Withholding Treatment
D000017:ABO Blood-Group System; D006680:HLA Antigens; D007519:Isoantigens; D011239:Prednisolone; D009173:Mycophenolic Acid; D016559:Tacrolimus
ABO blood group incompatibility; End-stage kidney disease; Lung transplantation; Renal transplantation